Biotech company Moderna said it plans to start phase 2 trials with 600 participants shortly.

The Kentucky senator waded into a contentious science debate with libertarian politics, saying 'the state doesn't own your children.' He shushed a TV host on camera when she cut off his long arguments.

A survey of five European countries revealed that parents in Spain have the most positive feelings towards vaccination, while their French counterparts have the least.

Scientists at Imperial College London found previously exposed to the dengue virus boosts the potency of Zika, explaining why cases in Brazil, where the former is rife, have soared.

Two studies released today have identified antibodies to fight Zika. They have been hailed as some of the most precise investigations into Zika to date as the virus sweeps the world.

Even with pre-clinical and early stage clinical trials underway, we still may not see a Zika vaccine licensed and approved for use in humans for years.

Two weeks ago, two British tourists in Florida were reported to have contracted Zika. The news came as the richest man in the world announced the details of a major project to tackle the problem.

None of the rats tested at Philadelphia's Wistar Institute contracted Zika after getting the vaccine. It is the best result of a Zika vaccine to date, and it is the same being tested in the first human trials.

A leading global health scientist has said that it is 'very unrealistic' that the Tokyo Olympics and Paralympics will take place next year unless a vaccine is discovered by then. 

The singer has announced that she has donated $1 million to the Gates Philanthropy Partners' COVID-19 Therapeutics Accelerator in order to help find a cure for coronavirus. 

The Russian leader used the video conference to demand a 'green corridor' in which key technology could be shared regardless of sanctions such as those on Moscow.

Boris Johnson and counterparts including Donald Trump, Xi Jinping of China, and Vladimir Putin linked up for a discussion on how to coordinate the response.

ModernaThe biotech Moderna is developing experimental cancer vaccines.The leading coronavirus vaccine candidate just got up to $483 million in additional funding from the US government.The cash will pay for future trials to see if the vaccine works in humans, as well as for simultaneously ramping up production of the vaccine. "This allows us to go full speed and very aggressively," CEO Stephane Bancel told Business Insider in a Thursday video interview, saying the vaccine program will now go "as fast as humanly possible."The upstart biotech Moderna developed the vaccine candidate in record time using its technology platform called messenger RNA. The new technology has yet to produce an approved vaccine, but has shown promise in its potential to quickly respond to new viruses. The first human

BCCLSanofi plans to get thousands of subjects onboard across the world for the trials of experimental coronavirus vaccines that it is developing with GSK. Once enrolled, the company will start early-stage trials in September. The pharma giant has already partnered with GlaxoSmithKline Plc (GSK) and is researching also exploring other options simultaneously. It hopes to introduce the vaccine next year, reported Reuters.Sanofi, a French multinational pharmaceutical company, says it is working on two different projects to develop a vaccine for COVID-19. The pharma giant has partnered with GlaxoSmithKline Plc (GSK) and is researching other options as well. It hopes to introduce the vaccine by next year, reported Reuters. The plan is to get thousands of subjects on board across the world to test

“Even after India approves the coronavirus vaccine, it might not be possible to produce more than 10-20 million doses in the first year.”The comments came from the Chairperson of Biocon in an exclusive chat with Business Insider.Syngene, a Biocon subsidiary, is involved in accelerating a bunch of initiatives to develop a vaccine for the novel coronavirus that is spreading around the world.There are at least six vaccines under development in India, of the total 100 around the world including from the likes of Sanofi, Altimmune, and Pfizer. “Indian vaccine programmes will take some time before they get into the clinical trials, I think between 6 to 9 months depending on the programme. At least the ones we are working on, I don’t think they can get to clinics before 9 months,” Kiran Mazumdar

Coronavirus vaccines by the University of Oxford and China are in the most advanced clinical phase and likely the best choice for India according to Biocon founder Kiran Mazumdar Shaw.The US coronavirus vaccine candidates may be more talked about but they will likely be much more expensive.“We’re much more comfortable with a jab and a low-cost vaccine, which is what the Oxford and Chinese vaccines are all about,” explained Shaw.Biotechnology companies around the world are going head-to-head to create the first coronavirus vaccine as the ongoing pandemic continues to wreak havoc on normal life. Some have a headstart over others.“I think the Oxford vaccine and Chinese vaccine are certainly in the more advanced clinical phase as is the German vaccine. The two US vaccines are, of course, much

On the 40th anniversary of the eradication of smallpox, the World Health Organization's director general said it's "a reminder of what's possible" when it comes the coronavirus. But he said the fight against smallpox had one crucial tool we don't yet have for COVID-19: a vaccine. Even after a vaccine was developed for smallpox, it took another 184 to completely eradicate the disease — a reminder of the long road ahead for conquering the coronavirus. Visit Business Insider's homepage for more stories.On May 8, 1980, the World Health Assembly officially declared smallpox eradicated.The disease had "plagued humanity for at least 3,000 years, and killed 300 million people in the 20th century alone," the World Health Organization director-general Tedros Adhanom Ghebreyesus said during a media briefing

Gold Coast Titans' Bryce Cartwright, Nathan Peats and Brian Kelly were informed they would be unable to play on Friday afternoon following talks between the NRL and Queensland Government.

Hackers from Russia and Iran have been attempting to gain access to British universities that are developing vaccines for the coronavirus. Pictured: Stock image of a hacker.

A new trial is underway for a coronavirus vaccine is underway at Oxford University in the UK involving more than 6,000 participants that will be started by the end of next month

Some institutions have said that if their coronavirus vaccine trials go well, its jab could be available as early as Fall 2020, but most people would not be able to get it until Fall 2021.

Scientists in Italy claim antibodies made against the virus in mice were able to kill the infection in human cells, but British researchers said the discovery was routine in vaccine development.

Moderna Inc has been greenlit by the FDA to conduct a trial of its vaccine. The company has received $483million in funding from the government to carry it out.

President Donald Trump expressed optimism that there would be a coronavirus vaccine by the conclusion of 2020.

President Trump's top official for public health preparedness, Robert Kadlec, dedicated billions in taxpayer dollars to fight biological and chemical weapons prioritizing that over battling a pandemic.

Dr Catherine Houlihan, from Aberdeen, returned home to the UK from the African nation in June after spending a month at the heart of the epidemic in the North Kivu province.

The so-called Merck vaccine was approved his afternoon and is likely to get a full marketing licence from the European Commission within a few weeks.

On Thursday, the US Food and Drug Administration approved Ervebo, the first vaccine against Ebola to get green lit by American officials. It comes as a Congo outbreak rages on and has killed 4 in Uganda.

Kate Broderick, 42, from Scotland, has been fighting infectious diseases for more than 20 years. She is working with colleagues at company Inovio, San Diego, to develop a vaccine.

Researchers at the US National Institutes of Health tested an experimental antiviral drug, first created for Ebola, on 18 rhesus macaques.

Researchers at Paris Descartes University have produced a video showing how a cell infected with HIV sprays the virus when it comes into contact with a healthy cell in order to spread the infection.

Researchers have created a new experimental vaccine that could neutralize dozens of strains of HIV by creating proteins that send antibodies to a vulnerable site of the virus.

A HIV vaccine is in sight after a team of scientists from the likes of Harvard and MIT tested a new drug that stopped two thirds of monkeys getting infected and boosted immune system of 400 adults.

Lockdown will make it difficult to assess the successful of a vaccine - such as that developed by University of Oxford - because it is preventing the spread of the virus globally.

The Health Secretary outlined the best-case scenario if global efforts to protect people from the deadly pathogen in a television interview this morning.

Research into coronavirus treatments has been boosted by an unlikely benefactor - an 82-year-old great-grandfather who is selling his multi-million dollar beachside penthouse.

President Donald Trump on Friday predicted the coronavirus would 'go away without a vaccine' and vowed that America is going to 'transition to greatness.'

Buttigieg (pictured), the Democratic mayor of South Bend, Indiana, initially said there could be 'personal or religious exemptions' allowing people to opt out of the injections.

The experimental vaccine being trialed by scientists at the University of Queensland is already generating immunity levels higher than in recovered coronavirus patients, researchers said.

The Australian scientists from the University of Queensland said the fast-tracked timeline was  'incredibly ambitious' but reflected overwhelming success in pre-clinical trials.

The world No 1 has suggested that he could delay his return to the tennis tour, were it to be made compulsory for him to take any safeguard that emerged against the virus.

In the UK there are two main contenders in the vaccine race: a team at the University of Oxford, and another at Imperial College London.

Glaxo said it would invest more than £200m in the US company and that they would initially focus on speeding up development of Vir's antibody drugs, which could be used to treat Covid-19.

Sir John Bell, Regius professor of medicine at Oxford University, said 'several hundred' people have now been given the jab in the first British trial to find a vaccine.

Perth-based Linear Clinical Research will trial a 'ground-breaking' potential vaccine being developed to help the body produce antibodies to fight the coronavirus.

The testing for China's fourth vaccine candidate has started today, said China National Biotec Group. It comes as CDC chief said that China could have its first coronavirus vaccine ready by autumn.

Researchers found fake vaccines were being sold with a median cost of $575, but some allegedly sourced from China were priced at $15,300 with the most expensive being sold for $24,598.

The United States and China are locked in a race to develop a coronavirus vaccine as fears mount that the latter country would use its success as economic and diplomatic leverage.

As a warning was sounded that a normal version of next year's Australian Open already looks out of the question, Nadal addressed the issue of potential rules which may have to be brought in.

The Prime Minister said the world needed to come together 'against our common enemy' as he boasted of the UK's £744 million commitment to a global response war chest.